Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / OXBDF - Oxford Biomedica signs DMLA with Beam Therapeutics for LentiVector platform for next generation CAR-T therapeutics

OXBDF - Oxford Biomedica signs DMLA with Beam Therapeutics for LentiVector platform for next generation CAR-T therapeutics

Oxford BioMedica
  • Oxford Biomedica (OTCPK:OXBDF) inks a new development, manufacture & license agreement with Beam Therapeutics (NASDAQ:BEAM) for LentiVector platform for next generation CAR-T Therapeutics.
  • More news on: Beam Therapeutics Inc., Oxford Biomedica plc, Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Oxford BioMedica
Stock Symbol: OXBDF
Market: OTC
Website: oxb.com
Menu
OXBDF OXBDF Quote OXBDF Short OXBDF News OXBDF Articles OXBDF Message Board
Get OXBDF Alerts

News, Short Squeeze, Breakout and More Instantly...